A phase II clinical study on the efficacy and predictive biomarker of pegylated recombinant arginase on hepatocellular carcinoma
一项关于聚乙二醇化重组精氨酸酶治疗肝细胞癌的疗效和预测性生物标志物的II期临床研究
期刊:Investigational New Drugs
影响因子:2.7
doi:10.1007/s10637-021-01111-8
Chan, Stephen L; Cheng, Paul N M; Liu, Angela M; Chan, Landon L; Li, Leung; Chu, Cheuk M; Chong, Charing C N; Lau, Yat M; Yeo, Winnie; Ng, Kelvin K C; Yu, Simon C H; Mok, Tony S K; Chan, Anthony W H